logo
Plus   Neg
Share
Email

Sanofi: European Commission Approves Supemtek Recombinant Influenza Vaccine

Sanofi (SNYNF,SNY) announced the European Commission has granted a marketing authorization for Supemtek, a quadrivalent (four-strain) recombinant influenza vaccine, for the prevention of influenza in adults aged 18 years and older. The first European launches are expected for the 2022/2023 influenza season, with a possibility of accelerating the availability of doses as early as the 2021/2022 season in certain countries.

Sanofi noted that Supemtek is the first and only recombinant influenza vaccine now approved in the European Union. Supemtek is produced using recombinant technology, and contains three times more antigen than standard-dose vaccines. The company noted that the increased amount of antigen and the use of recombinant technology provide improved protection against influenza, particularly in those aged 50 and older.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Goldman Sachs Group Inc. (GS) on Tuesday reported a fourth-quarter profit that more than doubled from last year, reflecting a surge in investment banking revenues and lower provisions for bad loans. Net revenues for the quarter rose 18 percent. Both quarterly earnings per share and revenues topped analysts' expectations. U.S. holiday retail sales in 2020 were unexpectedly high compared to last year and came in significantly higher than the previous forecast, according to the National Retail Federation or NRF. Retail sales for the November-December 2020 holiday season grew 8.3 percent from the prior-year period to $789.4 billion. The figures exclude automobile dealers, gasoline stations and restaurants. Milk supplier Hiland Dairy recalled one-half pint 1% low-fat chocolate milk that was produced at its facility in Norman, Oklahoma, according to the U.S. Food and Drug Administration. The affected milk may contain food-grade sanitizers that could cause illness if consumed. The recall was reported to have been initiated after unexpected illness was noticed among many children at a hospital.
Follow RTT